Jenburkt Pharmaceuticals Limited (BOM:524731)

Jenburkt Pharmaceuticals Revenue

Jenburkt Pharmaceuticals had revenue of 355.12M INR in the quarter ending June 30, 2026, a decrease of -0.04%. This brings the company's revenue in the last twelve months to 1.69B, up 9.08% year-over-year. In the fiscal year ending March 31, 2026, Jenburkt Pharmaceuticals had annual revenue of 1.69B with 11.24% growth.

• Revenue (ttm): 1.69B
• Revenue Growth: +9.08%
• P/S Ratio: 2.75
• Revenue / Employee: 2.11M
• Employees: 801
• Market Cap: 4.63B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.69B	170.49M	11.24%
Mar 31, 2025	1.52B	97.25M	6.85%
Mar 31, 2024	1.42B	52.17M	3.82%
Mar 31, 2023	1.37B	127.69M	10.30%
Mar 31, 2022	1.24B	146.86M	13.44%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error